These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 16171905)
1. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905 [TBL] [Abstract][Full Text] [Related]
2. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle. Clavijo A; Hole K; Li M; Collignon B Vaccine; 2006 Mar; 24(10):1693-704. PubMed ID: 16260073 [TBL] [Abstract][Full Text] [Related]
5. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle. Lee F; Jong MH; Yang DW Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061 [TBL] [Abstract][Full Text] [Related]
6. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus. Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400 [TBL] [Abstract][Full Text] [Related]
7. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123 [TBL] [Abstract][Full Text] [Related]
8. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan. Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687 [TBL] [Abstract][Full Text] [Related]
9. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC. Foord AJ; Muller JD; Yu M; Wang LF; Heine HG J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688 [TBL] [Abstract][Full Text] [Related]
11. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge. Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957 [TBL] [Abstract][Full Text] [Related]
12. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705 [TBL] [Abstract][Full Text] [Related]
13. Cedivac-FMD can be used according to a marker vaccine principle. Chénard G; Selman P; Dekker A Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508 [TBL] [Abstract][Full Text] [Related]
14. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India). Kumar N; Sharma R; Kakker NK Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976 [TBL] [Abstract][Full Text] [Related]
15. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines. Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500 [TBL] [Abstract][Full Text] [Related]
16. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies. Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662 [TBL] [Abstract][Full Text] [Related]
17. Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA. Armstrong RM; Cox SJ; Aggarwal N; Mackay DJ; Davies PR; Hamblin PA; Dani P; Barnett PV; Paton DJ J Virol Methods; 2005 May; 125(2):153-63. PubMed ID: 15794985 [TBL] [Abstract][Full Text] [Related]
18. Detection of foot-and-mouth disease virus infection in vaccinated cattle. Niedbalski W Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852 [TBL] [Abstract][Full Text] [Related]
19. Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays. Espinoza AM; Maradei E; Mattion N; Cadenazzi G; Maddonni G; Robiolo B; La Torre J; Bellinzoni R; Smitsaart E Vaccine; 2004 Nov; 23(1):69-77. PubMed ID: 15519709 [TBL] [Abstract][Full Text] [Related]
20. The NSP immune response of vaccinated animals after in-field exposure to FMDV. Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]